Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Shockwave Medical Inc (SWAV)

Shockwave Medical Inc (SWAV)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
CMS Grants Transitional Pass-Through (TPT) Payment for Shockwave's Coronary IVL

Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, announced today that the Centers for Medicare...

SWAV : 188.27 (-2.80%)
Shockwave Medical (SWAV) Reports Q1 Loss, Tops Revenue Estimates

Shockwave Medical (SWAV) delivered earnings and revenue surprises of -61.90% and 1.44%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

SWAV : 188.27 (-2.80%)
Shockwave Medical Reports First Quarter 2021 Financial Results

Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, today reported financial...

SWAV : 188.27 (-2.80%)
Shockwave Medical, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 10, 2021 / Shockwave Medical, Inc. (NASDAQ:SWAV) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 10, 2021 at 4:30 PM...

SWAV : 188.27 (-2.80%)
Medical Product Stock Q1 Earnings on May 10: MRVI, TGTX & More

The sector's Q1 results are likely to reflect solid earnings and revenue growth on strong base business recovery.

NSTG : 62.05 (+4.34%)
TGTX : 37.85 (+3.13%)
SWAV : 188.27 (-2.80%)
SDC : 9.10 (-1.19%)
MRVI : 44.89 (+0.94%)
CMS Proposes Additional Payment for Shockwave's Coronary IVL in Hospital Inpatient Cases

Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, announced today that the Centers for Medicare...

SWAV : 188.27 (-2.80%)
Shockwave Medical to Participate in the Bank of America Securities 2021 Health Care Conference

Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, announced today that the company will be participating...

SWAV : 188.27 (-2.80%)
Shockwave Medical to Report First Quarter 2021 Financial Results on May 10, 2021

Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, today announced it will...

SWAV : 188.27 (-2.80%)
Shockwave Provides Update on U.S. Launch of Coronary IVL System

Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, today announced a preliminary forecast revenue...

WFC : 42.79 (-6.10%)
SWAV : 188.27 (-2.80%)
Shockwave Appoints Sara Toyloy to Board of Directors

Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, announced today that Sara Toyloy has joined its...

SWAV : 188.27 (-2.80%)
Shockwave Announces Joint Venture in China

Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, announced today that the company has signed an...

SWAV : 188.27 (-2.80%)
Shockwave Medical (SWAV) Reports Q4 Loss, Tops Revenue Estimates

Shockwave Medical (SWAV) delivered earnings and revenue surprises of -12.20% and 11.60%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

SWAV : 188.27 (-2.80%)
Shockwave Medical Reports Fourth Quarter and Full Year 2020 Financial Results

Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, today reported financial...

SWAV : 188.27 (-2.80%)
Shockwave Medical, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / February 17, 2021 / Shockwave Medical, Inc. (NASDAQ:SWAV) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on February 17, 2021...

SWAV : 188.27 (-2.80%)
Shockwave Intravascular Lithotripsy FDA Approved to Treat Advanced Heart Disease

Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, announced today that the company's sonic pressure...

SWAV : 188.27 (-2.80%)
Will Shockwave Medical (SWAV) Report Negative Earnings Next Week? What You Should Know

Shockwave Medical (SWAV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

SWAV : 188.27 (-2.80%)
SWAV Crosses Above Average Analyst Target

In recent trading, shares of ShockWave Medical Inc have crossed above the average analyst 12-month target price of $76.80, changing hands for $82.00/share. When a stock reaches the target an analyst...

SWAV : 188.27 (-2.80%)
Shockwave Medical (SWAV) Reports Q3 Loss, Tops Revenue Estimates

Shockwave Medical (SWAV) delivered earnings and revenue surprises of 30.91% and 34.87%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

SWAV : 188.27 (-2.80%)
Shockwave Medical to Participate in Upcoming September Investor Conferences

Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, announced today that Shockwave management is scheduled...

WFC : 42.79 (-6.10%)
SWAV : 188.27 (-2.80%)
Shockwave Medical (SWAV) Reports Q2 Loss, Tops Revenue Estimates

Shockwave Medical (SWAV) delivered earnings and revenue surprises of 15.15% and 6.04%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

SWAV : 188.27 (-2.80%)

Barchart Exclusives

Gold Struggled At The $1900 Level
Gold failed at the $1900 level and dropped like a stone after the June FOMC meeting, but the prospects for higher prices remain compelling. Gold is a currency and a commodity with a bull market that has remained intact over the past two decades. Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar